Aclaris Therapeutics to Attend Upcoming Investor Conferences
February 02 2018 - 8:00AM
Aclaris Therapeutics, Inc. (NASDAQ:ACRS), a dermatologist-led
biopharmaceutical company focused on identifying, developing and
commercializing innovative and differentiated therapies to address
significant unmet needs in medical and aesthetic dermatology, today
announced that members of its management team will present and host
investor meetings at the following upcoming investor events:
- Dr. Neal Walker, President and Chief Executive Officer, will
present at the LEERINK Partners 7th Annual Global Healthcare
Conference in New York, NY on Wednesday, February 14, 2018 at 3:30
PM EST. Management will also host investor meetings on Wednesday,
February 14, 2018.
- Dr. Neal Walker, President and Chief Executive Officer, will
present at the Cowen and Company 38th Annual Health Care Conference
in Boston, MA on Tuesday, March 13, 2018 at 10:00 AM EST.
Management will also host investor meetings on Tuesday, March 13,
2018.
A live webcast of the LEERINK Partners 7th Annual Global
Healthcare Conference and the Cowen and Company 38th Annual Health
Care Conference presentation may be accessed through the Company's
web site, www.aclaristx.com, on the 'Events and Presentations'
section. An archived version of the presentation will be available
for 30 days.
About Aclaris Therapeutics, Inc.Aclaris
Therapeutics, Inc. is a dermatologist-led biopharmaceutical company
committed to identifying, developing and commercializing innovative
therapies to address significant unmet needs in aesthetic and
medical dermatology and immunodermatology. The Company focuses on
market segments with no FDA-approved medications or where treatment
gaps exist. Aclaris is based in Wayne, Pennsylvania. More
information can be found by visiting the Aclaris website at
www.aclaristx.com.
Contact:
Aclaris ContactMichael Tung, M.D. Vice President / Investor
Relations484-329-2140mtung@aclaristx.com
Media ContactMariann
CaprinoTogoRun917-242-1087M.Caprino@togorun.com
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Jun 2024 to Jul 2024
Aclaris Therapeutics (NASDAQ:ACRS)
Historical Stock Chart
From Jul 2023 to Jul 2024